Matters of Life and Death: Why Do Older Patients Choose Conservative Management?
Chronic kidney disease
Conservative management
Medical management without dialysis
Older adults
Journal
American journal of nephrology
ISSN: 1421-9670
Titre abrégé: Am J Nephrol
Pays: Switzerland
ID NLM: 8109361
Informations de publication
Date de publication:
2020
2020
Historique:
received:
29
09
2019
accepted:
09
11
2019
pubmed:
28
11
2019
medline:
9
2
2021
entrez:
28
11
2019
Statut:
ppublish
Résumé
Although many older patients with end-stage renal disease and limited prognoses prefer conservative management (CM), it is not widely offered in the United States. Moreover, there is a dearth of US-based literature reporting clinical experience with shared decision making regarding CM of advanced chronic kidney disease (CKD). We describe the clinical experience of 13 patients who opted for CM at the University of Rochester Medical Center's CKD clinic during 2016-2017. Main outcomes include: (1) reason for choosing CM, (2) completion of advance directives, (3) location of death, and (4) utilization of hospice service. Patients' reasons for choosing CM were categorized into 4 broad categories based on a review of their electronic medical records. A retrospective chart review conducted by 2 reviewers determined the status of advance care planning, hospice referral, and place of death. The mean age of these patients was 81.8 years (SD 7.3). Their reasons for choosing CM included: poor prognoses; a wish to maintain their quality of life; their desire for a dignified life closure; and the intention to protect family members from having to see them suffer, based on their own memory of having witnessed a relative on dialysis previously. A total of 8 patients died: all received hospice services, 6 died at home, one at a nursing home, and one at a hospital. Advance care planning was completed in 100% of the cases. Symptoms were managed in collaboration with primary care physicians. Patients' decisions to choose CM were influenced by their values and previous experience with dialysis, in addition to comorbidities and limited prognoses. Promoting the choice of CM in the United States will require training of clinicians in primary palliative care competencies, including communication and decision-making skills, as well as basic symptom management proficiencies.
Sections du résumé
BACKGROUND
Although many older patients with end-stage renal disease and limited prognoses prefer conservative management (CM), it is not widely offered in the United States. Moreover, there is a dearth of US-based literature reporting clinical experience with shared decision making regarding CM of advanced chronic kidney disease (CKD).
METHODS
We describe the clinical experience of 13 patients who opted for CM at the University of Rochester Medical Center's CKD clinic during 2016-2017. Main outcomes include: (1) reason for choosing CM, (2) completion of advance directives, (3) location of death, and (4) utilization of hospice service. Patients' reasons for choosing CM were categorized into 4 broad categories based on a review of their electronic medical records. A retrospective chart review conducted by 2 reviewers determined the status of advance care planning, hospice referral, and place of death.
RESULTS
The mean age of these patients was 81.8 years (SD 7.3). Their reasons for choosing CM included: poor prognoses; a wish to maintain their quality of life; their desire for a dignified life closure; and the intention to protect family members from having to see them suffer, based on their own memory of having witnessed a relative on dialysis previously. A total of 8 patients died: all received hospice services, 6 died at home, one at a nursing home, and one at a hospital. Advance care planning was completed in 100% of the cases. Symptoms were managed in collaboration with primary care physicians.
CONCLUSION
Patients' decisions to choose CM were influenced by their values and previous experience with dialysis, in addition to comorbidities and limited prognoses. Promoting the choice of CM in the United States will require training of clinicians in primary palliative care competencies, including communication and decision-making skills, as well as basic symptom management proficiencies.
Identifiants
pubmed: 31775149
pii: 000504692
doi: 10.1159/000504692
pmc: PMC10073899
mid: NIHMS1887540
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
35-42Subventions
Organisme : NIDDK NIH HHS
ID : K23 DK121939
Pays : United States
Informations de copyright
© 2019 S. Karger AG, Basel.
Références
Clin Interv Aging. 2016 Oct 17;11:1455-1461
pubmed: 27799751
Am J Kidney Dis. 2018 May;71(5):627-635
pubmed: 29396240
Am J Kidney Dis. 2016 Apr;67(4):688-95
pubmed: 26709108
JAMA. 2011 Apr 20;305(15):1553-9
pubmed: 21482743
Clin J Am Soc Nephrol. 2017 Jun 7;12(6):1001-1009
pubmed: 28377472
BMC Nephrol. 2018 Aug 16;19(1):205
pubmed: 30115028
Nephrol Dial Transplant. 2007 Jul;22(7):1955-62
pubmed: 17412702
Nephrol Nurs J. 2004 Jul-Aug;31(4):461
pubmed: 15453241
Am J Kidney Dis. 2019 Feb;73(2):153-155
pubmed: 30545706
J Oncol Pract. 2014 Sep;10(5):e335-41
pubmed: 25118208
Am J Kidney Dis. 2020 Feb;75(2):167-176
pubmed: 31570175
Am J Kidney Dis. 2018 May;71(5):732-736
pubmed: 29433828
Clin J Am Soc Nephrol. 2010 Dec;5(12):2380-3
pubmed: 21051749
Clin J Am Soc Nephrol. 2013 Oct;8(10):1783-90
pubmed: 23744000
JAMA Intern Med. 2019 Mar 1;179(3):305-313
pubmed: 30667475
Clin J Am Soc Nephrol. 2013 Apr;8(4):675-80
pubmed: 23143502
Clin J Am Soc Nephrol. 2009 Oct;4(10):1611-9
pubmed: 19808244
Hepatology. 2001 Feb;33(2):464-70
pubmed: 11172350
Clin J Am Soc Nephrol. 2010 Jan;5(1):72-9
pubmed: 19965531
CMAJ. 1988 Jul 15;139(2):121-4
pubmed: 3390780
Clin J Am Soc Nephrol. 2017 Nov 7;12(11):1762-1770
pubmed: 28923833
N Engl J Med. 2009 Oct 15;361(16):1539-47
pubmed: 19828531
Nephrol Dial Transplant. 2008 Mar;23(3):789-91
pubmed: 18192324
J Am Geriatr Soc. 2011 Feb;59(2):304-8
pubmed: 21275929
J Nephrol Soc Work. 2012 Summer;36:
pubmed: 25242897
Am J Respir Crit Care Med. 2016 Jan 15;193(2):154-62
pubmed: 26378963
Am J Kidney Dis. 2019 Feb;73(2):174-183
pubmed: 30482578
J Gerontol B Psychol Sci Soc Sci. 2010 Mar;65B(2):195-201
pubmed: 20067977
Clin J Am Soc Nephrol. 2019 Jul 5;14(7):1039-1047
pubmed: 31248948
Nephrol Dial Transplant. 2013 Nov;28(11):2815-23
pubmed: 23901048
Clin Nephrol. 2019 May;91(5):294-300
pubmed: 30663974
Can J Kidney Health Dis. 2014 Oct 21;1:24
pubmed: 25780613
Kidney Int. 2014 Sep;86(3):475-80
pubmed: 24988063
Am J Kidney Dis. 2015 Feb;65(2):233-9
pubmed: 25245300
Nurs Res Pract. 2011;2011:408024
pubmed: 22229086
Kidney Int. 2015 Sep;88(3):447-59
pubmed: 25923985
Nephrol Dial Transplant. 2019 Sep 1;34(9):1517-1525
pubmed: 30395311
J Am Soc Nephrol. 2018 Dec;29(12):2870-2878
pubmed: 30385652
J Palliat Med. 2002 Oct;5(5):759-62
pubmed: 12572982
N Engl J Med. 1991 Aug 29;325(9):658-60
pubmed: 1861702
N Engl J Med. 2013 Mar 28;368(13):1173-5
pubmed: 23465068
Clin J Am Soc Nephrol. 2008 Sep;3(5):1379-84
pubmed: 18596118
CMAJ. 2012 Mar 20;184(5):E277-83
pubmed: 22311947
Nephrol Dial Transplant. 2011 May;26(5):1608-14
pubmed: 21098012
Clin J Am Soc Nephrol. 2016 May 6;11(5):812-20
pubmed: 27084874